Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 50 min ago
Peer-reviewedCC BY-NC-NDThoracic Cancer

SRC Activation Drives Acquired Pemetrexed Resistance in Non‐Small Cell Lung Cancer and Is Targetable by Dasatinib

  • Jeongmin Seo1
  • Kui‐Jin Kim2
  • Se Hyun Kim1
  • Ji Hea Sung1
  • Sung‐Hyun Hwang2
  • Woochan Park1
  • Minsu Kang1
  • Eun Hee Jung1
  • Sang‐A Kim1
  • Koung Jin Suh1
  • Ji Yun Lee1
  • Ji‐Won Kim1
8 more authors
  • Jeong‐Ok Lee1
  • Jin Won Kim1
  • Yu Jung Kim1
  • Keun‐Wook Lee1
  • Jee Hyun Kim1
  • Soo‐Mi Bang1
  • Ji‐Hyun Kwon3
  • Jong Seok Lee1
  1. 1Seoul National University Bundang Hospital, Seoul National University College of Medicine
  2. 2Seoul National University Bundang Hospital
  3. 3Chungbuk National University College of Medicine
Read full textPDFCite

Related

  1. An Immunocompetent Mouse Model of Degarelix Induced Chemical Castration to Investigate Acquired Resistance to Androgen Deprivation.
    A. Robotham, D. Costanzo-Garvey, G. Waldron +2
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. EGFR/TBK1-dependent mitochondrial quality control contributes to acquired resistance to temozolomide
    Lisenn Lalier, François Guillonneau, Jennifer Derrien +7
    Molecular & Cellular ProteomicsPeer-reviewedCC BY 4.0Epidemiology & public healthCrossrefHAL
  3. Mathematical Analysis of a Two-Strain Tuberculosis Model Incorporating Treatment Success, Acquired Drug Resistance, Reactivation, and Reinfection
    Ishtiaq Ali
    MathematicsPeer-reviewedCC BY 4.0Epidemiology & public healthCrossref
  4. Triple Genetic Alterations (EGFR Mutation, ALK Fusion, and MET Polysomy) in Gynecological Metastasis of Lung Adenocarcinoma Patient with Acquired Resistance to Furmonertinib: A Case Report.
    Qinglong Jiang, Rui Sun, Haiyan Xu +1
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  5. Acquired TRAIL Resistance Promotes Cancer Stemness and Malignant Behavior through CD44-SPHK1-STAT3 Signaling in Colorectal Cancer
    Se Lim Kim, Byung Chul Jin, Seung Young Seo +1
    Biomolecules & TherapeuticsPeer-reviewedCC BY-NC 4.0Full textOncologyPMC

Cite

BibTeXRIS
BibTeX
@article{seo2026activation,
  title = {{SRC Activation Drives Acquired Pemetrexed Resistance in Non‐Small Cell Lung Cancer and Is Targetable by Dasatinib}},
  author = {Jeongmin Seo and Kui‐Jin Kim and Se Hyun Kim and Ji Hea Sung and Sung‐Hyun Hwang and Woochan Park and Minsu Kang and Eun Hee Jung and Sang‐A Kim and Koung Jin Suh and Ji Yun Lee and Ji‐Won Kim and Jeong‐Ok Lee and Jin Won Kim and Yu Jung Kim and Keun‐Wook Lee and Jee Hyun Kim and Soo‐Mi Bang and Ji‐Hyun Kwon and Jong Seok Lee},
  journal = {Thoracic Cancer},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13694200},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - SRC Activation Drives Acquired Pemetrexed Resistance in Non‐Small Cell Lung Cancer and Is Targetable by Dasatinib
AU  - Jeongmin Seo
AU  - Kui‐Jin Kim
AU  - Se Hyun Kim
AU  - Ji Hea Sung
AU  - Sung‐Hyun Hwang
AU  - Woochan Park
AU  - Minsu Kang
AU  - Eun Hee Jung
AU  - Sang‐A Kim
AU  - Koung Jin Suh
AU  - Ji Yun Lee
AU  - Ji‐Won Kim
AU  - Jeong‐Ok Lee
AU  - Jin Won Kim
AU  - Yu Jung Kim
AU  - Keun‐Wook Lee
AU  - Jee Hyun Kim
AU  - Soo‐Mi Bang
AU  - Ji‐Hyun Kwon
AU  - Jong Seok Lee
PY  - 2026
DA  - 2026/10/01
JO  - Thoracic Cancer
UR  - https://europepmc.org/article/PMC/PMC13694200
SN  - 1759-7706
ER  -